Global Med Technologies(R) Inc. to Announce Third Quarter Results On October 30th - Conference Call to Follow Release
October 16 2007 - 9:00AM
PR Newswire (US)
DENVER, Oct. 16 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international e-Health, medical information technology company,
today announced that it will report its third quarter results on
Tuesday, October 30, 2007, before the market open. The Company will
host a conference call at 4:30 p.m. EDT on the same day. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
Conference Call Details: Dr. Mick Ruxin, Chief Executive Officer,
Tom Marcinek, President and Chief Operating Office, and Darren
Craig, Manager of Finance, will discuss the third quarter results
and will be available to answer questions. The conference call will
be held on Tuesday, October 30, 2007, at 4:30 p.m. EST. Interested
parties are welcome to call the telephone numbers listed below,
five minutes prior to the start of the conference call. Callers
within the US should call: 1-866 789-9224. Callers that are outside
of the US should call: 1-706 679-9621. Callers should reference
"Global Med Technologies Earnings Conference Call" to the
conference call operator, and the conference call ID no. is:
20490215. An automated replay of the conference call will be
available from October 30th at 5:30 p.m. (EDT) until November 1st
at 11:59 p.m. (EDT). To access the replay, please call 1-800
642-1687 if within the US. Callers that are located outside of the
US should call: 1-706 645-9291 and enter Global Med's access code
of 20490215. The replay of the conference call will be available
from November 1st onward at Global Med's website at
http://www.globalmedtech.com/. About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international e-Health
medical information technology company providing information
management software products and services to the healthcare
industry. Its Wyndgate Technologies(R) division is a leading
supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers. Each
year, Wyndgate's products and services manage more than eight
million blood components, representing over 27% of the U.S. blood
supply. Wyndgate's products are also being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the Donor Doc(TM) interactive donor health history
questionnaire, SafeTrace(R) donor management system, and the
SafeTrace Tx(R) advanced transfusion management system, recently
patented, provide Vein-to-Vein(R) tracking from donor collection to
patient transfusion. For more information about Global Med's
products and services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/ . This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGODATASOURCE:
Global Med Technologies, Inc. CONTACT: Company, Michael I. Ruxin,
M.D. of Global Med Technologies, Inc., +1-303-238-2000, ; or
Investors, Paul Holm of H.L. Lanzet, Inc., +1-212-888-4570, , for
Global Med Technologies, Inc. Web site:
http://www.globalmedtech.com/ http://www.peoplemed.com/
http://www.wyndgate.com/
Copyright